News

The most anticipated drug launches in 2025

Leave a Comment / News / By

Get ready for a transformative year in medicine! In 2025, innovative therapies will reshape the pharmaceutical landscape. From next-gen immunotherapies for cancer to novel gene therapies for rare diseases, the future is promising. New advancements in neurological, cardiovascular, and mental health are set to impact lives significantly. With industry leaders like Pfizer and Novartis at the forefront, excitement is growing. Explore these developments and envision what lies ahead for patients and healthcare providers!

The most anticipated drug launches in 2025 Read More »

Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery

Leave a Comment / News / By

AI Revolution Accelerating Drug Discovery through AI Innovation Artificial Intelligence is revolutionizing the pharmaceutical sector. It empowers rapid analytics, streamlining workflows, and deriving insightful data. AI is not merely changing drug discovery; it’s shifting the paradigm of drug administration. Embrace the future of healthcare and see how AI integration can foster innovative solutions and enhance

Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery Read More »

Doctors could face suspension in the NMC investigation regarding pharma-sponsored trips.

Leave a Comment / News / By

The Allegations: A number of doctors are under investigation by the National Medical Commission (NMC) for allegedly accepting foreign trips sponsored by pharmaceutical companies. These trips are suspected to be in violation of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) rules, which prohibit pharmaceutical companies from offering foreign trips, gifts, and other inducements to

Doctors could face suspension in the NMC investigation regarding pharma-sponsored trips. Read More »

Pharma companies may have until December to comply with Schedule M norms.

Leave a Comment / News / By

What is Schedule M? Schedule M is a set of Good Manufacturing Practices (GMP) guidelines that pharmaceutical manufacturers in India must adhere to. These guidelines ensure the quality, safety, and efficacy of medicines. The regulations cover everything from facility design and equipment maintenance to quality control and documentation. Why the Revision? The revised Schedule M

Pharma companies may have until December to comply with Schedule M norms. Read More »

Use of Technology to Improve Drug Development Efficiency

Leave a Comment / News / By

The pharmaceutical industry has been slow to adopt technology, but there is a growing recognition of the potential benefits that technology can bring to drug development. The systematic review you mentioned identified four key ways that technology can be leveraged to gain efficiencies within drug development:Big data and AI can create efficiencies within the drug

Use of Technology to Improve Drug Development Efficiency Read More »

Scroll to Top
Skip to content